Injectable cell-laden gelatin-chondroitin sulphate hydrogels for liver in vitro models
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Sanchez-Gonzalez, E
- Naranjo-Alcazar, R
- Tort-Ausina, I
- Salmeron-Sanchez, M
Grupos
Abstract
Liver extracellular matrix-based models that precisely reproduce liver physiology and functions are required as 3D culture microenvironments for multiple applications in toxicology and metabolism, or for understanding the mechanisms implicated in liver disease. We introduced injectable gelatin-chondroitin sulphate (Gel/CS) hydrogels for culturing HepG2 cells, and evaluated the mechanical properties and functionality of cells in different Gel/CS compositions. The Gel/CS hydrogels exhibited soft mechanical properties and allowed the HepG2 culture. The characterisation and comparison of 3D cultures to standard monolayer systems revealed the regulation of key hepatic markers (i.e. CYP3A4, GSTA1) when cells were cultured in the Gel/CS hydrogels compared to 2D cultures, and also enhanced urea and albumin production, which would indicate increased cells functionality. This study underpins 3D in vitro models based on the Gel/CS hydrogels that can be used for different hepatology applications by offering increased predictivity and physiological relevance compared to current in vitro models.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0141-8130, 1879-0003
- Tipo:
- Article
- Páginas:
- 138693-138693
- PubMed:
- 39672443
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 1,100 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
International Journal of Biological Macromolecules ELSEVIER
Citas Recibidas en Web of Science: 3
Documentos
- No hay documentos
Filiaciones
Keywords
- Hydrogel; Gelatin; Chondroitin sulphate; HepG2 cells; Functionality; 3D culture
Proyectos y Estudios Clínicos
Nuevas tecnologías traslacionales para el tratamiento de enfermedades hepáticas: preacondicionamiento del hígado, nuevas fuentes celulares y biomateriales en terapia celular.
Investigador Principal: LAIA TOLOSA PARDO
PI21/00223 . INSTITUTO DE SALUD CARLOS III . 2022
Nuevos modelos multicelulares personalizados para el tratamiento y estudio de las enfermedades hepáticas
Investigador Principal: LAIA TOLOSA PARDO
CNS2022-135425 . MINISTERIO DE CIENCIA E INNOVACION . 2023
Cita
Sanchez E,Naranjo R,Tort I,DONATO MT,Salmeron M,TOLOSA L,GALLEGO G. Injectable cell-laden gelatin-chondroitin sulphate hydrogels for liver in vitro models. Int. J. Biol. Macromol. 2025. 288. p. 138693-138693. IF:8,700. (1).
Portal de investigación